Chembio Reports Second Quarter and First Half 2006 Financial Results (Business Wire via Yahoo! Finance)
MEDFORD, N.Y.----Aug. 14, 2006--Chembio Diagnostics, Inc. reported second quarter and first half 2006 financial results.

Amarillo Biosciences IND Application Passes FDA Review (SYS-CON Media)
Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR), today announced that the Company's Investigational New Drugapplication (IND) for idiopathic pulmonary fibrosis (IPF) has successfullypassed the FDA's 30-day review process and has been allowed to go intoeffect. A Phase II, 60-patient study to test low dose oral interferon as atreatment of chronic cough in IPF patients is on target to launch in